Compare
Astrana Health vs HCA Healthcare (ASTH vs HCA)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Astrana Health (ASTH) returned +3.8% and HCA Healthcare (HCA) +4.6%; so far this year the figures are +39.1% and +6.0%.
HCA Healthcare is the larger company by market value, about 53.6 times the size of Astrana Health.
On trailing earnings, ASTH trades at 31.9 times and HCA at 16.4 times.
Revenue grew +35.1% at ASTH and +5.8% at HCA over the last year.
ASTH pays no dividend. HCA yields 0.62%.
Data as of the latest close. Not investment advice.
Relative performance
| ASTH | HCA | |
|---|---|---|
| Price | $34.50 | $494.99 |
| 1-day | -11.56% | -2.46% |
| YTD | +39.06% | +6.03% |
| 1 year | +3.79% | +4.60% |
| 3 years | +13.82% | +119.64% |
| Market cap | $1.9B | $103.4B |
| P/E | 31.9 | 16.4 |
| P/S | 0.49 | 1.31 |
| P/B | 2.25 | — |
| Revenue growth | +35.10% | +5.80% |
| EPS growth | +440.00% | +16.50% |
| Gross margin % | 11.0 | — |
| Net margin % | 1.4 | 8.6 |
| ROE % | 6.2 | — |
| Debt / equity | 1.08 | — |
| FCF yield % | 5.2 | 5.8 |
| Dividend yield % | — | 0.62 |
| Beta | 0.59 | 0.22 |
| RSI (14) | 39.8 | 62.2 |
| Technical rating |